chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 years old. She stated that 8 or 9 days after receiving the vaccine, her arm started hurting and she developed a big red blotchy area that itched and swelled up; Patient developed a big red blotchy area; Itchy; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (4 years old. She stated that 8 or 9 days after receiving the vaccine, her arm started hurting and she developed a big red blotchy area that itched and swelled up), RASH MACULAR (Patient developed a big red blotchy area), PRURITUS (Itchy) and SWELLING (Swelling) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M2A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced SWELLING (Swelling). On 15-Feb-2021, the patient experienced LIMB DISCOMFORT (4 years old. She stated that 8 or 9 days after receiving the vaccine, her arm started hurting and she developed a big red blotchy area that itched and swelled up), RASH MACULAR (Patient developed a big red blotchy area) and PRURITUS (Itchy). At the time of the report, LIMB DISCOMFORT (4 years old. She stated that 8 or 9 days after receiving the vaccine, her arm started hurting and she developed a big red blotchy area that itched and swelled up), RASH MACULAR (Patient developed a big red blotchy area), PRURITUS (Itchy) and SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took some Tylenol and used 1% hydrocortisone cream to help treat it.
Client received the first dose of Pfizer 1 month prior to second COVID vaccine. Client inadvertently given  Moderna lot # 023M20A  for second dose of COVID vaccine on 3/2/21.  No adverse reaction observed during observation period.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 24-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.  The box of vials were received from a location on 14-Oct-2021. It was frozen when it was received and was immediately placed in the clinic vaccine freezer. The vials remained frozen until the date of use and were thawed in the vaccine refrigerator prior to use. The vials remained in the refrigerator between uses and each vial was discarded after the final appointment of the day. Only 1 vial was used per day between the hours of 8:00 A,M to 4:00 P.M. It was reported that 4 vials had been used/administered to the patient, 1 open/punctured and about half used. 5 vials remained unpunctured.
Information has been received from a physician concerning a 25 year old female who in June 2010, was vaccinated with the second dose GARDASIL. The patient complained that the second dose hurt more than the first. The patient received GARDASIL in her left arm and still complained of pain at the injection site. The patient did not seek medical attention. This is one of several reports received from the same source. Additional information has been requested.
IgAN with moderate interstitial nephritis; This literature-non-study case was reported in a literature article and describes the occurrence of IGA NEPHROPATHY (IgAN with moderate interstitial nephritis) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE: (privacy)     The patient's past medical history included SARS-CoV-2 infection.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IGA NEPHROPATHY (IgAN with moderate interstitial nephritis) (seriousness criterion medically significant). The patient was treated with PREDNISONE for IgA nephropathy, at an unspecified dose and frequency and RAMIPRIL for IgA nephropathy, at an unspecified dose and frequency. At the time of the report, IGA NEPHROPATHY (IgAN with moderate interstitial nephritis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy kidney: positive (Positive) positive. On an unknown date, Blood creatinine: 1.2 mg/dl 1.2 mg/dl, 2.5 mg/dl 2.5 mg/dl and 2.7 mg/dl 2.7 mg/dl. On an unknown date, Protein urine: 14.4 g/d 14.4 g/d. On an unknown date, Urine analysis: 21-30 rbc/hpf 21-30 RBC/hpf.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered IGA NEPHROPATHY (IgAN with moderate interstitial nephritis) to be possibly related.    No concomitant information were reported.  Company Comment: This is a literature case concerning a 43 years old, male patient with no clinical history who experienced the unexpected event of IGA NEPHROPATHY  The event occurred unknown days after the first dose of Moderna Covid 19 vaccine. The rechallenge was not applicable since only information about the first dose was disclosed The benefit-risk relationship of Moderna Covid 19 vaccine is not affected by this report.   This case was linked to MOD-2021-380949 (Patient Link).; Sender's Comments: This is a literature case concerning a 43 years old, male patient with no clinical history who experienced the unexpected event of IGA NEPHROPATHY  The event occurred unknown days after the first dose of Moderna Covid 19 vaccine. The rechallenge was not applicable since only information about the first dose was disclosed The benefit-risk relationship of Moderna Covid 19 vaccine is not affected by this report.
muscle weakness  not sure it is related  the survey just said a condition for which i saw a doctor
Information has been received from a health care professional concerning a 12 year old female who on 18-JUN-2007 was vaccinated with the first dose of GARDASIL an don 24-AUG-2007 was vaccinated with the second dose of GARDASIL and on 04-JAN-2008 was vaccinated IM with the third (0.5 ml) dose of GARDASIL. There was no concomitant medication. After receiving the third dose the patient experienced injection site reaction. At the time of reporting the patient still had significant pain on the injection site on her right arm and could not even lift her arm to write. Medical attention was sought. Patient had not recovered at the time of reporting. No product quality complaint was involved. Additional information has been requested.
Patient stated that arm is swollen with exudate/pus coming out of the arm that he received the injection in.
Information has been received from a health professional concerning a patient in kindergarten who was vaccinated with a dose of Varivax. On 01-APR-2006 the patient experienced chickenpox. Additional information has been requested.
Patient came in on 11/19/2021 new to the pharmacy. He gave 6/28/2002 as his DOB, and asked for the Janssen COVID-19 vaccine. On his patient questionnaire, he also wrote 6/28/2002 as his DOB, making him 19 years old. Right before vaccination patient verified DOB. He was vaccinated. 5 days later, he called and asked to change his DOB to 6/28/2005 (making him 16 years old). Janssen is not indicated for a 16-year-old. I called him, but he hasn't returned my messages.
Spontaneous urticaria that began ~10 days after dose 1, and has persisted 6 weeks after dose 2. Hives appear every 1-3 days in random area and random severity, ranging from a small patch of skin on arm/leg, to swollen lips and face, to entire back/torso covered in hives. Symptoms resolve within a day with antihistamine (benadryl, zyrtec), but will reappear in a few days.
Heart attack; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MYOCARDIAL INFARCTION (Heart attack) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MYOCARDIAL INFARCTION (Heart attack) (seriousness criteria hospitalization, disability, medically significant and life threatening). The patient was hospitalized on 14-Apr-2021 due to MYOCARDIAL INFARCTION. At the time of the report, MYOCARDIAL INFARCTION (Heart attack) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  No treatment information provided.  It was reported that three days after vaccination the patient had a heart attack. He was admitted to the ICU for three days, starting on 14-Apr-2021. He had seen his primary care doctor and his cardiologist multiple times since that incident and he was unsure of whether he should get the second vaccine dose or not..  Company comment: Very limited information regarding the event has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding the event has been provided at this time.  Further information has been requested.
This patient is under the age limit for Moderna vaccine and received his first dose 3/9/2021 at a mass vaccination event held by the clinic. No physical adverse reaction occurred with patient but a med error occurred due to the patient's age.
Pt came in on 10-26-12 with red injection site, size of golf ball, warm to touch, we marked area and are watching. Returned on 10/27/12 - site was a littler larger called on 10/28/12 - said everything looked a lot better (not as red, did not get any bigger).
Initial symptom was swollen lymph nodes in left armpit--where I got the shot. I am informed enough to know this means I had active antibodies that recognized the virus and attacked it. This lasted approximately 4 days.  After day 2, this began where I am today; occasional vertigo/loss of balance with persistent high blood pressure/headaches consistent with when I contracted Covid 11/2020. I have been to my primary doctor twice. The possibility of this being a vaccine reaction has never come up. It is as if I have the headache/blood pressure portion of Covid infection all over again.    There is no outcome yet. Having read other people's comments, it is a waste of time and money to get diagnostic tests, and physicians are guessing. No thank you,  I learned of these symptoms and this website from the many internet forums (one is listed above) where people are discussing their vaccine reactions. I never wanted this vaccine, but there is considerable pressure to get vaccinated, even when you contracted the virus. I feel vaccine passports are going to be forced on people. I regret the decision to do this.  My second shot is scheduled for 4/30, but I am cancelling it, I am certain this is Covid vaccine related. I am a very healthy and physically fit 58 year old that eats well. Don't drink, don't smoke, mainly vegetarian diet.
Generalized urticaria 6 days after receiving vaccines Tx - BENADRYL 25-50mg every 6 hours prn.
MD ordered Pentacel and Ipol vaccines and both were given.  Child has not had any adverse reactions.
Arm swelling, redness, pain, warm to touch all with in the 1st 24 hours and cont for the past 4 days, by day 4 redness "going down" per patient.
Treatment of COVID-19; Treatment of COVID-19; Paxlovid rebound (but worse symptoms than with covid 1st time round); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DISEASE RECURRENCE (medically significant) with onset 27Aug2022, outcome "recovering", described as "Paxlovid rebound (but worse symptoms than with covid 1st time round)"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19. Therapeutic measures were not taken as a result of disease recurrence.  Clinical course: No other medication in 2 weeks. Patient received Anti-viral treatment for COVID-19 with Paxlovid from 15Aug2022 to 20Aug2022.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
Temp up to 103.4 & Headache x 4 days. Tylenol & Alka-Seltzer.
5:00 pm-fever, chills, cough, muscle aches, sore, itchy eyes, sore throat. 6:00pm-Same as above plus rapid heartbeat and feeling of something stuck in the throat, light headed feeling.
Pt recvd vax 23NOV92 & 24NOV92 devel fatigue, & weakness which started in arms & spread to legs & neck; No further details were provided;
she had redness in her face/next day redness in her neck; a little itchy; This is a spontaneous report received from a Pfizer-sponsored program COVAX US Support. A contactable consumer reported a female patient of unspecified age received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on an unspecified date in 2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unknown date, the patient experienced redness in her face and slept for the day. The following day the patient had redness in her neck- a little itchy but no bumps. The patient was treated with allergy medications. "It" was gone for about a week and came back again. The outcomes of redness in her face, redness in her neck- a little itchy were unknown.  No follow-up attempts are possible. Information about lot number cannot be obtained.
on 7/15/2020, his right arm, where the Kinrix vaccine  and the proquad vaccine were given, got red, warm  and swollen approximately 7 1/2 in x 7 in wide/long
After the 4 months regular vaccines, my child had fever, feeling tired and we noticed that the baby did not response the same way as before. She lost the strength in her hands and foot, she did make any sounds any before. We decided to take her to the doctor and advised the situation. Dr. send her to neurologist for check up. Awaiting to appointment.
Muscle cramping worse in both legs (anterior thighs and calf?s) also hands and arms.  No treatment
Infant broke out in fine rash and erythema on face and torso 1 min after administering Rotateq vaccine. Provider notified immediately. No treatment required.
This spontaneous report as received from a healthcare worker refers to a female patient of unknown age who was not pregnant. The patient was vaccinated with first dose of GARDASIL (lot number, dose, route, site not reported) on an unknown date and the second dose on 08-NOV-2012. No other co-suspects were reported. No concomitant medications were reported. The patient could not move her arm and felt "flaccid" after receiving the second dose of GARDASIL on 08-NOV-2012. The patient had a mild reaction when she received the first dose in the past (date unspecified). The patient saw a nurse practitioner for medical attention. No treatment was given. No laboratory studies were performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
Very painful upper arm beginning next day.  Lasted for 4 days and began to feel much better. Then it became very painful again and that is the current situation.
This spontaneous report as received from a other health professional refers to a 65 year old male patient. There was no information about concurrent condition, historical medication and concomitant medication. On an unspecified date in 2012 the patient was vaccinated with ZOSTAVAX. On an unknown date in October 2016 the patient was diagnosed with shingles. It was unknown by reporter that treatment was given for the reporter or not. Patient seek medical attention. The outcome of shingles was unknown. Causality was unknown. Additional information has been requested.
The blood was heavy just the the first shot. The only different between this one and the other one was I knew that this would happen so I wasn't as scared. I started bleeding and I was very scared because I couldn't get the blood to stop. I had to stand in the bathtub because the blood was so heavy. I passed a bunch of blood clots that were black and I was extremely tired. I had minor cramps and that not normal for me my usual cycle last 3 days and its very light. I had to wear something like a diaper because the blood was so heavy. I had zero energy. I felt hot all the time. It was like a mixture of so many different things at once. I didn't take my temperature but I felt very hot. My cycle is now longer and heavier that it was before I took the shot. I also now have bad cramps whenever I have a cycle. I knew what to expect because this happened the last time I got my shot.
Patient received Pfizer COVID19 Vaccine for dose 1 and dose 2 of series. Patient received Moderna COVID19 Vaccine for her booster dose and influenza vaccination on 11/8 and developed a vasculitic rash on her legs one week later. Patient came into primary care office for a sick visit and evaluation. Patient stated legs felt warm to touch and felt like they were on fire. Patient was then referred out to dermatology who confirmed rash was associated with Moderna COVID vaccine. Patient was given unknown cream from dermatologist.
Systemic: Fainting / Unresponsive-Mild, Additional Details: pt has history of fainting after vaccinations. pt  began to have abnormal breathing similar to snoring after administration of first shingrix dose. pt fainted and recovered consciousness. paramedics were called. they took his blood pressure, o2, sat, HR, and blood sugar. All within normal limits. pt refused to go to er or receive additional care. He was driven home by his partner. pt has no drug allergies, currently on a statin that was initiated 2 weeks ago.
Side effects after the 1st dose.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects after the 1st dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects after the 1st dose.). At the time of the report, VACCINATION COMPLICATION (Side effects after the 1st dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Patient came in pharmacy stated he had received a flu shot  a couple of weeks ago and his arm was still sore. He stated the pain is not in one specific area, it comes and goes and that in certain positions he doesn't feel it as much. He says sometimes it hurts more at the shoulder and then sometimes its more at the elbow. He had no pain until he received the flu shot. He has taken some otc naproxen it has helped. He has not seen a doctor yet, but may if the pain does not subside.
Tinnitus in the form of a constant ringing in the bilateral ears developed within a month after receiving the COVID-19 vaccination. Symptoms (ringing in the ears) has progressively worsened over the past year since vaccunation.
Body aches, chills, low-grade fever at approximately 24 hours, arm pain, redness, heat at the site At 48 Hours - Rash in arm larger the immediate vaccine site - approximately from shoulder to elbow, heat, and redness, raised bumps, mild itch.  2 Weeks post - redness and bumps remain, though less concentrated.
Redness, swelling, soreness at injection site along with fatigue, headache and fever of 102F until 11/23/2015 at 4:00 PM.
pt presented to MD petechiae on the forearms & lowe extremities;had a mild fever & irritability;pt was transferred to hosp for admission to r/o sepsis;sepsis work up dx was meningitis, bacterial vs viral;final dx viral meningitis;
Soreness at injection site; Gastrointestinal discomfort; Resolution of symptoms from a prior COVID-19 infection; This is a spontaneous report from a contactable consumer. A 26-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 12Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown whether the patient received any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On an unknown date in Apr2021, the patient experienced soreness at injection site and gastrointestinal discomfort. It was reported that the patient was feeling much better 36 hours after the shot than before the shot, including resolution of symptoms from a prior COVID-19 infection (shortness of breath, lethargy, brain fog) that had been lingering for months prior to the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events soreness at injection site and gastrointestinal discomfort was resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
No symptoms in the summer until around September my lupus breakouts have started coming back up again and worse breakouts then I had before the shot. The breakouts had gone away completely and now they have become so bad that I had to go back to see the dermatologist. I also have experienced really loud tinnitus in both ears.
Tuesday evening - severe headache and body aches. Wednesday morning better - then complete numbness in left upper leg quadricep area, pain in mid back on the left side, but no headache.  Went to nurse at employer just to check things out.  Took vitals - I had a fever of 99.9 degrees F, my BP was very high for me at 135/95, and my pulse was 111.  Took some deep breaths and drank some water, rested for ~ 5 minutes. Retook vitals and the results were nearly the same (slightly lower but not by much.)  That evening after traveling home I went to bed at 6:15 pm. I had the chills and felt very feverish (my neck, face and forehead were VERY hot, while the rest of me was very cold.) I do not have a thermometer at home so could not take temperature.  The next morning when I woke up I felt much better. Then only remaining pain in my left arm for two more days.  Now I'm feeling myself again.